Effects of Radial Extracorporeal Shockwave Therapy Versus 1% Lidocaine Injection for Myofascial Trigger Points Measured with Elastic Index

Areerat Suputtitada; Carl PC Chen; Narin Ngamrungsiri; Christoph Schmitz

doi:10.1101/2021.04.04.21254889

ABSTRACT

Purpose To compare the efficacy of radial extracorporeal shockwave therapy (rESWT) versus injection of 1% lidocaine for active myofascial trigger points (MTPs) at upper trapezius muscle (UTM) objectively with elastic index analysis.

Patients and methods A prospective, randomised, single-blinded clinical trial was done. 60 patients with active MTPs of UTM were randomised to receive either rESWT (n = 30); three rESWT sessions; one session per week; 2000 rESWT impulses per session; positive energy flux density = 0.10 mJ/mm2) or 1% lidocaine (4 ml) injection (n = 30) (three injections; one injection per week). The outcome measure was the elastic index of MTPs, visual analogue score (VAS score) of pain, and pressure pain threshold (PPT) three weeks after baseline.

Results Both rESWT and injection of 1% lidocaine resulted in statistically significant (P < 0.05) reduced elastic index and VAS of pain of UTM and PPT significantly (P < 0.05) at three weeks after baseline. The mean differences between rESWT and injection of 1%lidocaine showed no statistically siginificance.

Conclusion Both rESWT and 1% lidocaine injection had efficacy for active MTPs of UTM measured with elastic index, VAS of pain and PPT.

Highlights

Extracorporeal shockwave therapy (ESWT) is an alternative to 1%lidocaine injection for myofascial trigger points (MTPs).
Elastic index provides evidence for the quantitative assessment of MTPs.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

TCTR20160330003

Funding Statement

This study received a grant from Ratchadapiseksomphot Endowment Fund, Faculty of Medicine, Chulalongkorn University,Bangkok.Thailand.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (Protocol No.: 222/57; date of approval by the ethics committee: September 17, 2015) before starting the study, and was carried out in accordance with the World Medical Association (WMA) Declaration of Helsinki

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

This study received a grant from Ratchadapiseksomphot Endowment Fund, Faculty of Medicine, Chulalongkorn University, Bangkok.Thailand.
The preliminary data was presented at the 9^th International Society of Rehabilitation Medicine Congress in 2015 and published as the abstract in Annals of Physical medicine and Rehabilitation 61 e2 20.
The authors declare no conflicts of interest in this work.